A new autologous keratinocyte dressing treatment for non-healing diabetic neuropathic foot ulcers

Diabetic Medicine

Volumn 21, Issue 7, 2004, Pages 786-789

  Moustafa, M ^a   Simpson, C ^a   Glover, M ^a   Dawson, R A ^a   Tesfaye, S ^b   Creagh, F M ^a   Haddow, D ^c   Short, R ^c   Heller, S ^a   MacNeil, S ^a,c  

^a NORTHERN GENERAL HOSPITAL   (United Kingdom)

^b ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

^c UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Chronic wounds; Neuropathic foot ulcers

Indexed keywords

CARBOXYLIC ACID DERIVATIVE; METICILLIN; POLYMER; WOUND HEALING PROMOTING AGENT;

ADULT; AGED; ARTICLE; CELL ADHESION; CELL ISOLATION; CELL PROLIFERATION; CELL SURFACE; CLINICAL ARTICLE; CONTROLLED STUDY; DELIVERY; DIABETIC FOOT; FOLLOW UP; FREEZING; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; KERATINOCYTE; NEUROPATHY; NON INSULIN DEPENDENT DIABETES MELLITUS; RECURRENT DISEASE; SKIN BIOPSY; STAPHYLOCOCCUS AUREUS; THAWING; THICKNESS; TREATMENT OUTCOME; WOUND DRESSING; WOUND HEALING;

ADULT; AGED; BANDAGES; CHRONIC DISEASE; DIABETIC FOOT; HUMANS; KERATINOCYTES; MIDDLE AGED; SKIN, ARTIFICIAL; TREATMENT OUTCOME; WOUND HEALING;

EID: 3142656803     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2004.01166.x     Document Type: Article

References (18)

1. Edmonds M, Boulton A, Buckenham T, Every N, Foster A, Freeman D et al. Report of the diabetic foot and amputation group. Diabet Med 1996; 13: S27-42.
2. Ehrlichman R, Seckel BR, Bryan DJ, Moschella CJ. Common complications of wound healing. Prevention and management. Surg Clin North Am 1991; 71: 1323-1351.
3. Delmaire M, Mangendre D, Moreno M, Le Gof MC, Allannic H, Genetet B. Impaired leucocyte functions in diabetic patients. Diabet Med 1997; 14: 29-34.
4. Pecoraro RE, Reiber GE, Burges EM. Pathways to diabetic limb amputation. Basis for prevention. Diabetes Care 1990; 13: 513-521.
5. Currie CJ, Morgan CL, Peters JR. The epidemiology and cost of inpatient care for peripheral vascular disease, infection, neuropathy and ulceration in diabetes. Diabetes Care 1998; 21: 42-48.
6. Thomson FJ, Veves A, Ashe H. A team appproach to diabetic foot care - The Manchester experience. The Foot 1991; 2: 75-82.
7. Sibbald RG, Kensholme A, Carter L. Special foot clinics for patients with diabetes. J Wound Care 1996; 5: 238-243.
8. Spencer S. Pressure relieving interventions for preventing and treating diabetic foot ulcers. Cochrane Review. Cochrane Database Syst Rev 3, 2000 [In Process Citation].
9. Steed DL, Donohoe D, Webster MW, Lindsley L. Effect of extensive debridement and treatment on the healing of diabetic foot ulcers. Diabetic Ulcer Study Group. J Am Coll Surg 1996; 183: 61-64.
10. Robson MC. The role of growth factors in the healing of chronic wounds. Wound Rep Regen 1997; 5: 12-17.
11. Weiman TJ. Clinical efficiency of Becaplermin (rh PDGF-BB) gel. Am J Surg 1998; 176: 74S-79S.
12. Tibbles PM, Edelsberg JS. Hyperbaric-oxygen therapy. N Engl J Med 1996; 334: 1642-1648.
13. Pollak RA, Edington H, Jensen JL, Kroeker RO, Gentzkow GD. The Dermograft Diabetic Ulcer Study Group: A human dermal replacement for the treatment of diabetic foot ulcers. Wounds 1997; 9: 175-183.
14. Veves A, Falanga V, Armstrong DG, Sabolinski ML. Graftskin, a human skin equivalent, is effective in the management of noninfected neuropathic diabetic foot ulcers. Diabetes Care 2001; 24: 290-295.
15. France RM, Short R, Duval E, Jones F, Dawson R, MacNeil S. Plasma copolymerization of allyl alcohol/1,7-octadiene: surface characterization and attachment of human keratinocytes. Chem Materials 1998; 10: 1176-1183.
16. Haddow DB, Steele DA, Short RD, Dawson RA, MacNeil S. Plasma polymerised surfaces for culture of human keratinocytes and transfer of cells to an in vitro wound bed model. J Biomed Materials Res 2003; 64: 80-87.
17. Armstrong DG, Larvey LA, Kimbriel HR, Nixon BP, Boulton AJ. Activity patterns of patients with diabetic foot ulceration: patients with active ulceration may not adhere to a standard pressure off-loading regimen. Diabetes Care 2003; 26: 2595-2597.
18. Rennekampff HO, Kiessig V, Loomis W, Hansbrough JF. Growth peptide release from biologic dressings: a comparison. J Burn Care Rehab 1996; 17: 522-527.